O

Optima Health PLC
OTC:OHLTF

Watchlist Manager
Optima Health PLC
OTC:OHLTF
Watchlist
Price: 2.65 USD 14.22% Market Closed
Market Cap: $235.3m

Wall St Price Targets

OHLTF Price Targets Summary
Optima Health PLC

Wall Street analysts forecast OHLTF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OHLTF is 2.81 USD with a low forecast of 2.7 USD and a high forecast of 3.03 USD.

Lowest Forecast
Price Target
2.7 USD
2% Upside
Average Forecast
Price Target
2.81 USD
6% Upside
Highest Forecast
Price Target
3.03 USD
14% Upside
Optima Health PLC Competitors:
Price Targets

Revenue
Forecast

-5% / Year
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-5% / Year
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 31%.

Gross Profit
Forecast

-5% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-5% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Gross Profit has been -5%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

-4% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-4% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 8 years is 21%.

Pre-Tax Income
Forecast

90% / Year
Past Growth
87% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
90% / Year
Past Growth
87% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 90%. The projected CAGR for the next 3 years is 87%.

Net Income
Forecast

2% / Year
Past Growth
128% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
128% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 128%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OHLTF's stock price target?
Price Target
2.81 USD

According to Wall Street analysts, the average 1-year price target for OHLTF is 2.81 USD with a low forecast of 2.7 USD and a high forecast of 3.03 USD.

What is the Revenue forecast for Optima Health PLC?
Projected CAGR
31%

Over the last 2 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 31%.

What is the Gross Profit forecast for Optima Health PLC?
Projected CAGR
11%

Over the last 2 years, the compound annual growth rate for Gross Profit has been -5%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Optima Health PLC?
Projected CAGR
21%

Over the last 2 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 8 years is 21%.

What is the Pre-Tax Income forecast for Optima Health PLC?
Projected CAGR
87%

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 90%. The projected CAGR for the next 3 years is 87%.

What is the Net Income forecast for Optima Health PLC?
Projected CAGR
128%

Over the last 2 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 128%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett